Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Int J Mol Sci. 2021 Aug 20;22(16):8965. doi: 10.3390/ijms22168965.
Int J Mol Sci. 2021.
PMID: 34445670
Free PMC article.
Review.
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells.
Moody R, Wilson K, Jaworowski A, Plebanski M.
Moody R, et al.
Cancers (Basel). 2020 Mar 13;12(3):673. doi: 10.3390/cancers12030673.
Cancers (Basel). 2020.
PMID: 32183059
Free PMC article.
Review.
Item in Clipboard
Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity.
Moody R, Wilson KL, Boer JC, Holien JK, Flanagan KL, Jaworowski A, Plebanski M.
Moody R, et al.
Front Bioinform. 2021 Aug 19;1:709533. doi: 10.3389/fbinf.2021.709533. eCollection 2021.
Front Bioinform. 2021.
PMID: 36303764
Free PMC article.
Item in Clipboard
Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes.
Moody R, Sonda S, Johnston FH, Smith KJ, Stephens N, McPherson M, Flanagan KL, Plebanski M.
Moody R, et al.
Front Immunol. 2022 Aug 11;13:945021. doi: 10.3389/fimmu.2022.945021. eCollection 2022.
Front Immunol. 2022.
PMID: 36032086
Free PMC article.
Item in Clipboard
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy.
Moody R, Wilson K, Kampan NC, McNally OM, Jobling TW, Jaworowski A, Stephens AN, Plebanski M.
Moody R, et al.
Cancers (Basel). 2021 Aug 20;13(16):4201. doi: 10.3390/cancers13164201.
Cancers (Basel). 2021.
PMID: 34439354
Free PMC article.
Item in Clipboard
Cite
Cite